-
-
Pfizer RSV Vaccine Approval
Pfizer
Pfizer's RSV vaccine, Abrysvo, has received FDA approval for use in high-risk adults aged 18-59, expanding its reach beyond older adults and pregnant women. This decision follows a successful Phase III trial, promising enhanced protection against respiratory syncytial virus (RSV) infections.
-
-
-
-
-
宁津县|
富阳市|
巍山|
沙河市|
蓬溪县|
邓州市|
宁陵县|
海伦市|
通道|
德钦县|
宁津县|
壶关县|
富宁县|
莆田市|
武邑县|
永顺县|
城市|
普宁市|
珲春市|
札达县|
武义县|
开阳县|
兴安盟|
新野县|
拉萨市|
丰镇市|
莱芜市|
荔波县|
海兴县|
扬州市|
遂溪县|
青海省|
盐山县|
淳安县|
广饶县|
理塘县|
台中市|
额尔古纳市|
曲阳县|
嘉定区|
佛山市|